Pharmacological Potential of Marine Algae: A Review of Bioactive Compounds and Therapeutic Applications

Background : Marine algae, ranging from microscopic microalgae to larger seaweeds, have been the subject of much attention in recent years due to their nutraceutical and pharmacological value. They are broadly classified into four classes - brown algae (Phaeophyta), green algae (Chlorophyta), red algae (Rhodophyta) and blue-green algae (Cyanophyta), having their own pigments and metabolic pathways. These taxonomic differences are important to identify species that produce specific bioactive compounds, such as well-known metabolites such as carrageenan, fucoidan, astaxanthin and phlorotannins. Aim : The aim of this review is to explore the biochemical composition, taxonomy, and extraction methods of marine algae, and to focus on the therapeutic potential and relevance to pharmaceutical, cosmetic and biomedical applications. Methods : The published literature on algae-derived bioactive substances such as polyphenols, polysaccharides, proteins, pigments, sterols and lipids and their related biological effects was reviewed. The review also explores emerging biotechnological approaches, such as enzyme-assisted extraction, strategies to increase metabolite yield, and CRISPR-based methods for improving therapeutic utility. Results : Bioactive compounds from marine algae display a wide range of biological activities such as anti-inflammatory, antioxidant, anticancer, antimicrobial, cardioprotective and antiviral activities. Therapeutic suitability is closely related to the pigment and metabolite composition characteristic of each taxonomic group. Advances in extraction technology and biotechnology are enabling incorporation of these compounds into nanoformulations and targeted drug-delivery platforms, expanding opportunities in drug development. Conclusion : Marine algae are sustainable, eco-friendly alternatives to synthetic pharmaceutical agents, with lower toxicity and good bioavailability. However, there are still obstacles in areas like standardisation of cultivat

View article page

Download PDF